We are live on ! Find out more
HCWB icon

HCW Biologics
HCWB

12 hedge funds and large institutions have $516K invested in HCW Biologics in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

221% more capital invested

Capital invested by funds: $161K → $516K (+$355K)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

7.96% more ownership

Funds ownership: 20.91% → 28.86% (+8%)

8% less funds holding

Funds holding: 13 → 12 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$282K
2
Citadel Advisors
Citadel Advisors
Florida
+$88.4K
3
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust
Pennsylvania
+$35.1K
4
CCM
Connective Capital Management
California
+$18.9K
5
TRCT
Tower Research Capital (TRC)
New York
+$9.32K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$175K
2
VF
Virtu Financial
New York
-$17K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$12.9K
4
UBS Group
UBS Group
Switzerland
-$8.71K
5
Citigroup
Citigroup
New York
-$3.79K

HCWB Hedge Fund Activity: Q2 2026 in Review

12 of the 8,330 institutional investors tracked by Wall St. Rank reported a position in HCW Biologics (HCWB) for Q2 2026, worth a combined $516K — up 221% from $161K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of HCWB and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 4 added.

The largest buyer was Jane Street, adding an estimated $282K. The largest seller was HRT Financial, cutting an estimated $175K.

  • 12 institutional investors held HCW Biologics (HCWB) as of Q2 2026, down from 13 in Q1 2026.
  • Funds reported $516K of HCW Biologics stock for Q2 2026, up 221% quarter-over-quarter.
  • 3 funds opened new HCW Biologics positions in Q2 2026 and 4 closed out, a net change of -1 holder.
  • The largest HCW Biologics buyer in Q2 2026 was Jane Street, an estimated $282K added.
  • The largest HCW Biologics seller in Q2 2026 was HRT Financial, an estimated $175K sold.

Based on aggregated 13F filings for Q2 2026.